Page last updated: 2024-08-16

temozolomide and chitosan

temozolomide has been researched along with chitosan in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (75.00)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Benoit, JP; Boesen, K; Lagarce, F; Messaoudi, K; Saulnier, P1
Di Martino, A; Sedlarik, V1
Benoit, JP; Danhier, F; Lagarce, F; Lemaire, L; Messaoudi, K1
Fan, L; He, J; Qiao, Y; Tan, J; Wang, Q; Wu, H; Yang, Q; Zhang, Y1
Budriene, S; Di Martino, A; Maciulyte, S; Pavelkova, A; Sedlarik, V1
Haririan, I; Irani, M; Mir Mohamad Sadeghi, G1
Gupta, L; Gupta, U; Nakhate, KT; Qayum, A; Sahu, H; Sharma, AK; Singh, SK1
Chang, FC; Erickson, AE; Lan Levengood, SK; Sun, J; Zhang, M1
Afjei, R; Babikir, HA; Bose, RJC; Chang, E; Gambhir, SS; Habte, F; Malhotra, M; Massoud, TF; Paulmurugan, R; Robinson, E; Sinclair, R; Sukumar, UK; Zeng, Y1
Iyer, AK; Jain, S; Kashaw, SK; Kushwah, V; Sahu, P; Sau, S1
Bazzazzadeh, A; Dizaji, BF; Irani, M; Kianinejad, N; Nouri, A1
Azambuja, JH; Braganhol, E; de Cássia Sant'ana, R; de Souza, PO; Debom, GN; Fachel, FNS; Gelsleichter, NE; Lenz, GS; Michels, LR; Roliano, GG; Teixeira, FC; Teixeira, HF; Visioli, F1

Other Studies

12 other study(ies) available for temozolomide and chitosan

ArticleYear
Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Acylation; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Synergism; ErbB Receptors; Gene Silencing; Glioblastoma; Humans; Lipids; Nanocapsules; Particle Size; RNA, Small Interfering; Temozolomide; Treatment Outcome

2014
Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy.
    International journal of pharmaceutics, 2014, Oct-20, Volume: 474, Issue:1-2

    Topics: Chitosan; Dacarbazine; Doxorubicin; Drug Delivery Systems; Humans; Lactic Acid; Male; Molecular Structure; Nanoparticles; Particle Size; Polyesters; Polymers; Surface Properties; Surface-Active Agents; Temozolomide; Temperature

2014
Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation.
    International journal of pharmaceutics, 2015, Mar-15, Volume: 481, Issue:1-2

    Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Female; Galectin 1; Gene Silencing; Glioblastoma; Humans; Lipids; Mice, Nude; Nanocapsules; RNA, Small Interfering; Temozolomide; Tumor Burden

2015
Dual loading miR-218 mimics and Temozolomide using AuCOOH@FA-CS drug delivery system: promising targeted anti-tumor drug delivery system with sequential release functions.
    Journal of experimental & clinical cancer research : CR, 2015, Sep-25, Volume: 34

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chitosan; Dacarbazine; Delayed-Action Preparations; Drug Delivery Systems; Fatty Acids; Female; Glioblastoma; Gold Compounds; Humans; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanogels; Polyethylene Glycols; Polyethyleneimine; Sulfhydryl Compounds; Temozolomide; Xenograft Model Antitumor Assays

2015
Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016, Sep-20, Volume: 92

    Topics: Alginates; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Chitosan; Dacarbazine; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Drug Stability; Fluorouracil; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Pectins; Prodrugs; Temozolomide

2016
A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.
    International journal of biological macromolecules, 2017, Volume: 97

    Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitosan; Dacarbazine; Drug Carriers; Drug Liberation; Humans; Kinetics; Nanofibers; Nanoparticles; Polyesters; Polyurethanes; Temozolomide

2017
Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
    Pharmaceutical research, 2018, 01-02, Volume: 35, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Brain; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dacarbazine; Dendrimers; Drug Liberation; Drug Stability; Glioma; Half-Life; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Rats; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Temozolomide; Tissue Distribution

2018
Fabrication and Characterization of Chitosan-Hyaluronic Acid Scaffolds with Varying Stiffness for Glioblastoma Cell Culture.
    Advanced healthcare materials, 2018, Volume: 7, Issue:15

    Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Glioblastoma; Humans; Hyaluronic Acid; Temozolomide; Tissue Scaffolds; Tumor Microenvironment

2018
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Biomaterials, 2019, Volume: 218

    Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Resistance, Neoplasm; Ferric Compounds; Glioblastoma; Gold; Humans; Mice; MicroRNAs; Temozolomide; Theranostic Nanomedicine; Xenograft Model Antitumor Assays

2019
Discovering pH triggered charge rebound surface modulated topical nanotherapy against aggressive skin papilloma.
    Materials science & engineering. C, Materials for biological applications, 2020, Volume: 107

    Topics: Animals; Apoptosis; Biocompatible Materials; Cell Line; Chitosan; Down-Regulation; Drug Carriers; Drug Liberation; Gels; Hemolysis; Humans; Hydrogen-Ion Concentration; Male; Melanoma; Mice; Nanostructures; Organotechnetium Compounds; Particle Size; Skin Neoplasms; Temozolomide

2020
Fabrication of poly(acrylic acid) grafted-chitosan/polyurethane/magnetic MIL-53 metal organic framework composite core-shell nanofibers for co-delivery of temozolomide and paclitaxel against glioblastoma cancer cells.
    International journal of pharmaceutics, 2020, Sep-25, Volume: 587

    Topics: Acrylic Resins; Cell Line, Tumor; Chitosan; Glioblastoma; Humans; Magnetic Phenomena; Metal-Organic Frameworks; Nanofibers; Paclitaxel; Polyurethanes; Temozolomide

2020
Metastatic Melanoma: A Preclinical Model Standardization and Development of a Chitosan-Coated Nanoemulsion Containing Temozolomide to Treat Brain Metastasis.
    Cellular and molecular neurobiology, 2023, Volume: 43, Issue:6

    Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chitosan; Dacarbazine; Humans; Melanoma; Mice; Temozolomide

2023